© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Chemistry has a way of circling back on itself. In the late twentieth century, specialty phosphine ligands started turning heads among chemists who needed solutions for catalysis and advanced synthesis. TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO didn’t just appear out of thin air. Researchers working on ligand tuning wanted materials with both water solubility and robust coordination behavior. Around the nineties, academic labs, especially in Europe, looked for phosphine derivatives that would open new doors in homogeneous catalysis. Teams began to adapt trisphosphines by adding carboxyethyl groups. Adding a hydrochloride function was a practical move: it handled storage and made the material straightforward to manipulate under standard laboratory conditions.
TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO doesn’t sound glamorous, but among those who use it, the compound stands out for its versatility. The structure is that of a phosphine core surrounded by three carboxyethyl arms, each ending with a –COOH group. The hydrochloride part plays a crucial role. It stabilizes the free phosphine against oxidation and allows for easier handling. Chemists see this ligand as a workhorse for transition metal complexes, especially where water-soluble catalysts are needed or where carboxy functionality opens up new reactivity.
TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO appears as an off-white powder with a faint acidic smell, easily recognized in the lab. At room temperature, it stays stable, especially with proper sealing and away from light. Solubility in water sets it apart from classic trialkylphosphines, making it useful for applications that can’t tolerate organic solvents. With its carboxylate groups, the compound carries a negative charge in basic or neutral conditions, while under acidic situations it stays mostly protonated. The hydrochloride salt form raises the melting point and lends itself to bench stability, something chemists always appreciate if they deal with air-sensitive materials. Under standard analytical techniques, like NMR and FTIR, clear signatures for phosphine and carboxylate stretches make identification and purity checks straightforward.
Manufacturers usually supply TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO at purities above 98%. Moisture content matters: sustained exposure to air may cause partial hydrolysis, so suppliers package the compound in sealed glass bottles, sometimes with desiccant pouches. Labels cover everything from batch number to lot analysis, offering information on melting point, NMR spectrum, and weight percentage of phosphorus. Material Safety Data Sheets often recommend specific storage: cool, dry, away from strong oxidizers. Why so many details? Because in catalysis, impurities—even the tiniest speck—lead to poor yields or strange byproducts. Well-labeled reagents mean smoother workflows and fewer headaches.
Making TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO isn’t rocket science but it does demand a steady hand and solid lab technique. It starts with the base phosphine, often triphosphine, which reacts with bromoacetic acid or its derivatives via a nucleophilic substitution mechanism. This approach grafts carboxyethyl arms onto the phosphorus atom. Later, hydrochloric acid protonates the amine functionality, converting the molecule into its hydrochloride salt. After the reaction, repeated recrystallizations from cold water or ethanol help get rid of byproducts. Bulk production relies on careful pH control: letting acidity drift risks over-hydrolysis, which ruins yields. Quality control technicians keep a close watch with titration, NMR, and even ion chromatography for chloride assay.
The heart of TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO’s chemistry lies in its ability to coordinate transition metals. Those carboxylate groups not only boost solubility in water—they also act as extra handles for engaging in hydrogen bonding, metal chelation, or further derivatization. Researchers often use the ligand to synthesize water-soluble palladium or rhodium complexes aimed at cross-coupling reactions in green solvents. Some labs experiment by converting the carboxyethyl side arms to esters or amides, opening options for targeted modifications. The parent phosphine’s nucleophilic character remains largely inert unless exposed to strong oxidants or alkyl halides, at which point oxidation or quaternization occurs. That flexibility means creative chemists haven’t exhausted its possibilities yet.
You won’t always spot “TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO” on a label. In practice, chemists refer to it as “Tris(2-carboxyethyl)phosphine hydrochloride” or TCEP·HCl for short. Some catalogs stick to this common name, while commercial suppliers might highlight its abbreviations for the sake of busy researchers flipping through hundreds of chemical options. In protocol writeups, you sometimes see “TCEP Hydrochloride.” Variability in names reflects language and regional preferences but doesn’t change the core identity, so cross-checking ensures labs use the same compound batch after batch.
Chemists working with this substance handle it thoughtfully because phosphorus reagents sometimes show unexpected reactivity. Direct contact with skin or mucous membranes stings due to its acidic nature, so gloves and goggles become standard. Ventilation matters: anyone grinding or weighing the powder generates fines that shouldn’t linger in the air. The hydrochloride form lessens the threat of fire or explosion compared to more volatile phosphines. Disposal routines require neutralization, especially when dealing with spent catalysts or reaction residues—local waste protocols spell out the details. Routine risk assessment remains part of daily life in research labs to tamp down on accidents.
TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO grabs most attention in biochemical and catalytic settings. Molecular biologists use it as a reducing agent, especially for breaking disulfide bonds in proteins without generating foul-smelling byproducts—unlike classic dithiothreitol (DTT). In organometallic chemistry, it serves as a ligand for water-tolerant catalysts, powering reactions from Suzuki couplings to asymmetric hydrogenations. Environmental chemists choose it to explore “green” catalysis in water, often reporting better recyclability and reduced toxicity compared to older phosphine analogs. For analytical brains, its stability and reactivity mean cleaner, faster results—no fiddly byproducts to clean up. Some even probe its potential in medicine, where mild reducing power and biocompatibility pair up for bioconjugation and drug delivery.
Academic and industrial labs continue to test new uses. On the protein side, streamlined workflows with TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO have helped mass spectrometry analysts cut down sample preparation times while protecting delicate protein structures. Synthetic chemists keep redesigning ligands built on the carboxyethylphosphine backbone, trading carboxylic acids for other functionalities to tweak selectivity or boost binding to specific metal ions. The ligand also finds a place in environmental remediation, serving as a binding agent for heavy metal cleanup. Research effort keeps shifting as new problems crop up in energy storage, drug design, and catalysis, so this compound’s future path remains wide open.
No one likes surprises with chemical toxicity. Early screening showed that TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO shows much lower toxicity compared to many phosphine compounds. Researchers observed minimal mutagenicity in cell models and moderate acute toxicity in rodents at high doses. The compound degrades slowly under typical conditions, so it doesn’t bioaccumulate in soil or water. For human exposure, the main worry comes from skin or eye contact—prompt washing removes residues, and no significant long-term effects have been reported at normal lab levels. Toxicologists recommend against inhaling the powder or ingesting concentrated solutions. Waste management protocols keep it out of municipal water, but the risk factor remains considerably less than with many common transition metal ligands or reducing agents.
TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO keeps showing up in places beyond its origins. As cleaner synthesis and eco-friendly catalysis gain ground, more researchers gravitate toward water-soluble, less hazardous ligands. Biochemistry, environmental clean-up, and precision medicine loom on the horizon. Chemists aiming for faster, safer, and more selective reactions continue to lean on this compound’s adaptability. Its structure leaves plenty of room for further modifications—so labs anywhere can tweak it to hit whatever target modern chemistry sets. If new energy or pharmaceutical breakthroughs rely on sturdy ligands and reliable reducing agents, this compound’s story is far from finished.
The name sounds like a mouthful—TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO. Sure, it rings some bells for chemists and scientists in the pharmaceutical or industrial fields. We spot this compound, also called TCEP hydrochloride in English, showing up in labs where there’s a need for reliable, strong reduction reactions. People looking for a safer alternative to older toxic reducing agents regularly put TCEP on their inventory list.
In years spent talking to biochemists, the mention of TCEP often comes up during protein studies. Plenty of labs trust TCEP for its ability to keep proteins from tangling up through disulfide bonds. That’s crucial when trying to isolate a specific protein’s function, a task that can easily get sidetracked by unwanted chemical reactions. Research journals have reported TCEP being less smelly and less hazardous than its older cousin dithiothreitol (DTT). The switch to TCEP cuts down safety hazards without losing effectiveness.
Drug design often leans on clean, controlled chemical reactions. The pharmaceutical world pays attention to purity and safety, so agents that work under mild conditions and leave fewer toxic residues matter. TCEP fits neatly in that category. Manufacturers create active ingredients or reformulate drugs, knowing TCEP will help break chemical bonds and build new ones. Some vaccine production lines count on these kinds of chemicals to keep materials stable, something I’ve heard from pharmacists working in vaccine quality control.
Anyone with a background in chemical manufacturing hears regular complaints about safety risks. TCEP stands out for being less flammable and giving off fewer hazardous fumes. Industrial workers appreciate the reduced risk to health, especially those who remember rougher chemicals from ten or twenty years ago. That means fewer accidents and a smaller chance of environmental leaks or contamination. A safer workplace can mean a more productive team, and companies with lower risk ratings deal with fewer insurance headaches.
It isn’t all roses. Some recent studies have raised questions about phosphine derivatives and long-term exposure risks. As science keeps marching forward, environmental agencies keep tabs on possible groundwater or air risks, pressing for safer disposal and better containment procedures. Every chemical has a lifecycle, and TCEP isn’t exempt from broader calls for sustainable practices.
TSEP has replaced a lot of older, harsher chemicals, but labs and factories still have plenty of work ahead to train staff, invest in greener technology, and improve waste handling. Regular safety reviews and updates matter. Rather than simply swapping one chemical for another, leaders in pharma and industry should regularly revisit whether cleaner, plant-based or biodegradable alternatives can do the same job.
TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO has found a place in science and manufacturing for good reasons: safety, reliability, and efficiency. Speaking from experience, the direction points toward responsible innovation. We need to not only rely on compounds like TCEP while they meet a clear need, but keep an eye on the science and prepare to move again when an even better option comes along.
Spending years around laboratories and chemical inventories reveals that not all compounds have the same impact on human health. Some are harmless, some carry hidden risks that only show up after repeated exposure or larger doses. TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO sits in the group of specialty chemicals with a purpose, often in industrial and research settings. Curious eyes often overlook the small print that describes the cost of carelessness—actual side effects, sometimes subtle, sometimes immediate.
Handling phosphine-derivative compounds like this one raises immediate concern for skin and eye irritation. Without gloves or goggles, contact can cause redness, burning or sensitivity. Over time, repeated contact sometimes means eczema, dry skin, or rashes that flare up long after the workday ends. Inhaling dust or fumes leads to coughing, throat irritation, and breathing discomfort. Everyone breathes differently; for those with asthma or allergies, even minor exposures can trigger symptoms that last for days.
The less-obvious effects concern people the most. Prolonged exposure or accidental ingestion can affect organs like the kidneys and liver. The body treats unfamiliar chemicals as threats and ramps up its defense systems, sometimes producing nausea or headaches, sometimes causing fatigue or loss of appetite. These symptoms sneak into daily life unnoticed before anyone realizes the connection back to that vial in the corner of the lab.
Looking at the published studies and safety data sheets, one thing stands out—current information leaves gaps. Researchers have not scratched the surface regarding chronic toxicity or cancer risk for TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO. That invisible uncertainty stays in the back of every chemist’s mind. A lot of these specialty chemicals come with government safety guidelines that only address acute symptoms; missing long-term monitoring leaves workers guessing about their risks. Asking companies or researchers to be honest and clear about what they know, even if that means admitting they don’t have all the answers, carries weight.
The stories that stick with scientists are almost never about flawless experiments—they’re about accidental exposures and regret. Wearing personal protective equipment, keeping proper ventilation, and doing routine air checks reduce the odds of feeling those side effects after a shift. Talking openly with colleagues about little health changes avoids normalization of symptoms. Reporting health problems or exposures should never carry risk of being blamed or sidelined. After all, no job or research breakthrough matters as much as personal health.
Safety data only helps so far without continuous updates and oversight. Labs and factories benefit from regular reviews of their chemical use and storage. Calling on employers to provide both training and access to health professionals supports early intervention for side effects. Medical surveillance gives folks the chance to spot trends, not just one-off cases. Regulatory agencies could push for more transparency around hazardous properties, pressuring manufacturers to invest in robust toxicological research before a product becomes commonplace.
Experience proves that prevention pays off more than wishful thinking after exposure. Reading up on the side effects of TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO, knowing your rights at work, and championing transparency in chemical safety go farther than waiting for someone else to notice a problem. Health stays irreplaceable, and vigilance is the first line of defense.
TRIS 2 Carboxietil Fosfina Clorhidrato carries a technical name, but at its core, it’s a specialized chemical that ends up in sensitive settings, from labs to large-scale industrial projects. Tossing a chemical like this onto a shelf or just into a regular cabinet misses the big picture. A careless approach can pose risks to health, research, and manufacturing. From my own time working in labs with fussy reagents, small missteps in storage can snowball into ruined experiments and dangerous conditions.
Chemicals like TRIS 2 Carboxietil Fosfina Clorhidrato go hand-in-hand with strict handling rules for a reason. Ignoring the guidelines doesn’t just lead to regulatory trouble; it’s a recipe for damaged product, accidents, and lost money. Experienced chemists and warehouse workers stick to these basics:
Every good protocol means nothing if the person unpacking a shipment isn’t given the time or incentive to follow it. I’ve worked next to coworkers new to handling chemicals, and the ones without proper training can make costly mistakes, like leaving caps loose or missing leaks. Regular refresher sessions—quick but focused—remind everyone what’s at stake. It’s practical and shows respect for the work and the people doing it.
Busy labs and factories sometimes slide when it comes to labeling or tracking chemicals. That’s a short path to confusion, lost materials, and unreported spills. Labelling every container with clear, durable tags, including lot numbers and storage requirements, isn’t just tidy—it prevents mix-ups. Inventory checks every few months, with accountability tied to specific people, make sure no containers go forgotten or degrade past their prime.
Improper storage leaks into larger risks—airborne vapors, spills, or leaks that reach water sources. In places with strict regulations, poor storage comes with fines or worse, but even in looser environments, the ethical responsibility stands. Good storage habits, born out of real-world experience, respect both human safety and environmental impact.
Asking if a prescription comes with TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO makes a lot of sense. Few people outside chemistry or pharmacy circles have ever seen this long name printed on a bottle. This isn’t a vitamin supplement picked up off a neighborhood drugstore shelf. The chemical, which sometimes shows up in clinical research and pharmaceutical production, sparks plenty of questions about safety and legality for regular folks.
No over-the-counter vendor in the pharmacy section keeps chemicals like this in their regular assortment. Health agencies watch distribution closely, and for good reason. If people could easily buy highly specialized compounds, unexpected risks would multiply. Unsafe handling or mistakes at home could trigger health emergencies, not just for one person but for communities as well. Safety regulations from groups like the FDA in the United States or EMA in Europe don’t pop up without a reason. They rely on decades of medical incidents, evidence, and expert insight.
During my graduate work, researchers used chemicals under tightly controlled circumstances. Even small missteps resulted in reviews and, sometimes, project shutdowns. Colleagues who tried to move compounds for inter-lab work faced mountains of paperwork, for good reason. Even trained specialists with decades of experience approach these substances with care. Not everyone can spot contamination or hazardous interactions right away. That experience shaped the lesson that prescription requirements prevent misuse—not just intentional abuse, but accidents too.
For compounds with medical value, any drug entering the patient care system should pass tests for purity and reliability. Pharmacies play a role in making sure each dose matches exact standards. If there were no prescriptions or oversight, people could get counterfeit or contaminated versions online. That risk alone causes medical groups to keep tight restrictions.
Every year, health authorities track poisonings that start with black-market chemicals or medication mix-ups. Unregulated access to research chemicals means greater odds of hospital visits, unexpected side effects, or worse. Direct experience in the field showed me that overstretched emergency rooms deal with these disasters far too often. Without firm rules, more people would get caught in these traps.
For TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO, its use sits mainly with science teams and pharmaceutical development. It hasn’t shown up on public “safe for general use” lists, so a prescription acts as a checkpoint. Doctors, pharmacists, and industry regulators form a barrier to reckless use.
Sensible regulation points people in the right direction. If someone has a real medical need involving this substance, a physician can guide the process, starting from diagnosis through proper treatment. For researchers, established sourcing channels paired with institutional oversight help keep everyone honest and safe. Regulatory agencies, from national agencies down to hospital boards, invest years clarifying these rules and updating lists as new evidence comes in.
Some argue for wider liberalization, believing knowledge and responsibility should suffice. Experience from inside clinics and labs suggests caution saves more lives. No one benefits from an emergency set off by an unknown powder or mislabeled vial from the web. In a world crowded with new chemical compounds, sticking to trusted advice, prescriptions, and regulatory checks keeps people and their communities healthier.
TRIS 2 Carboxietil Fosfina Clorhidrato doesn’t show up in the local pharmacy or dominate everyday headlines. Folks working with this phosphine compound tend to come from research backgrounds—chemist, biochemist, or someone handling specialty reagents in a lab. So, figuring out the proper dosage or quantity to use isn’t about just flipping to a page in a medicine handbook. It calls for targeted safety information, published studies, and manufacturer expertise.
Search through reputable sources—Merck, Sigma-Aldrich, and peer-reviewed journals. Nobody hands a universal “standard dosage.” Instead, methods and concentrations depend on the exact experiment, the role of the compound, the medium, and the outcome you’re aiming for. In my own lab work, I’ve learned that assuming all phosphine derivatives behave the same spells out problems later.
The best answer to most dosage questions revolves around context: cell culture, catalysis, redox buffering, or enzyme modification. For instance, chemists working on peptide synthesis or catalytic reactions might find research that calls for concentrations in the micromolar to millimolar range. Researchers studying protein modification or reduction need even more careful calibration, often drawing procedure details from journals like Journal of Biological Chemistry or Angewandte Chemie.
Most people jump straight to product data sheets. Global suppliers provide technical bulletins, hazard communication, and handling instructions. These are essential reads. Yet in every workshop or university I’ve worked with, a responsible researcher never stops at the PDF. Batch differences can matter. Stability and reactivity in solution can throw off calculations. When I started handling similar phosphine compounds, I always cross-checked against previous publications and even called tech support for their recommendations—nobody wants to see their expensive experiment ruined by a dosing oversight or, worse, cause exposure risks.
Fosfina compounds aren’t household soaps. Wrong amounts can create hazardous fumes or destabilize entire experiments. Studies document accidental overuse leading to both failed results and real health risks. Environmental Safety Data Sheets, like those reviewed by PubChem or the European Chemicals Agency, outline immediate steps to limit exposure. Labs often lean on local biosafety committees or chemical hygiene officers for additional oversight.
Dosing comes down to specifics: working concentrations, buffer composition, endpoints. The gold standard in every project I’ve run relies on a tight paper trail. By noting batch numbers, mixing protocols, and even supplier lot information, teams save themselves headaches and make research reproducible for the next group. Going this route also supports the “traceability” piece highlighted by regulatory agencies and respected chemical hygiene programs worldwide.
Anyone faced with dosing TRIS 2 Carboxietil Fosfina Clorhidrato for the first time should start by piloting a small-scale reaction drawn from published protocols, then follow up with careful scaling based on observed outcomes. Keep open communication with technical reps and biosafety officers. Rely on up-to-date literature, supplier safety sheets, and institutional guidelines. These practical steps reflect not just scientific rigor, but the responsibility owed to those in the lab and beyond.
| Names | |
| Preferred IUPAC name | tris(2-carboxyethyl)phosphanium chloride |
| Other names |
TRIS(2-carboxyethyl)phosphine hydrochloride TCEP hydrochloride TCEP·HCl |
| Pronunciation | /trɪs tuː kɑːrˈbɒksiˌiːθɪl fɒsˈfiːnə klɔːrˈhɪdreɪtoʊ/ |
| Identifiers | |
| CAS Number | 10488-90-5 |
| 3D model (JSmol) | Here is the **JSmol 3D model string** (in SMILES notation) for **TRIS(2-carboxyethyl)phosphine hydrochloride (TCEP·HCl)**: ``` C(CP(CC(=O)O)CC(=O)O)P(CC(=O)O)CC(=O)O.Cl ``` |
| Beilstein Reference | 1721017 |
| ChEBI | CHEBI:132770 |
| ChEMBL | CHEMBL2285338 |
| ChemSpider | 143602 |
| DrugBank | DB04393 |
| ECHA InfoCard | echa.europa.eu/infocard/100.107.807 |
| EC Number | 2076203 |
| Gmelin Reference | 45623 |
| KEGG | C05996 |
| MeSH | D017929 |
| PubChem CID | 6918006 |
| RTECS number | TH3675000 |
| UNII | S7H2B63I92 |
| UN number | UN3276 |
| CompTox Dashboard (EPA) | CompTox Dashboard (EPA) of product 'TRIS 2 CARBOXIETIL FOSFINA CLORHIDRATO' is "DTXSID5025029 |
| Properties | |
| Chemical formula | C6H15ClNO6P |
| Molar mass | 242.63 g/mol |
| Appearance | white powder |
| Odor | characteristic |
| Density | 1.3 g/cm3 |
| Solubility in water | soluble |
| log P | -1.3 |
| Acidity (pKa) | 6.7 |
| Basicity (pKb) | 4.5 |
| Magnetic susceptibility (χ) | Diamagnetic |
| Refractive index (nD) | 1.473 |
| Dipole moment | 7.21 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 302.6 J/mol·K |
| Std enthalpy of formation (ΔfH⦵298) | -1098.5 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1815 kJ/mol |
| Pharmacology | |
| ATC code | B06AB10 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | P264, P280, P302+P352, P305+P351+P338, P332+P313, P337+P313 |
| Flash point | > 231.1 °C |
| Lethal dose or concentration | LD50 (rat, oral): 1320 mg/kg |
| LD50 (median dose) | LD50 (median dose): 600 mg/kg (oral, rat) |
| NIOSH | EW2150000 |
| PEL (Permissible) | PEL (Permissible): Not established |
| REL (Recommended) | Sea agua bidestilada |
| Related compounds | |
| Related compounds |
TRIS(2-carboxyethyl)phosphine TRIS(2-carboxyethyl)phosphine hydrochloride TCEP TCEP-HCl TRIS(2-carboxyethyl)phosphine hydrochloride hydrate Triscarboxyethylphosphine |
